Mylan Institutional, Inc. recalls Levothyroxine Sodium Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Subpotent and Superpotent Drug
- Products
-
- Levothyroxine Sodium Tablets
- Company
- Mylan Institutional, Inc.
- Where it was sold
-
Nationwide in the USA.
Nationwide
- Units affected
- 2,835 cartons
- About this recall
- Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-442-20